Question 1

What is PatentVest?

Accepted Answer

PatentVest is a Entity.

Question 2

How often does PatentVest appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was PatentVest first tracked by Ergen?

Accepted Answer

First tracked on May 08, 2026.

Question 4

When was PatentVest last mentioned in news?

Accepted Answer

Last active on Jul 23, 2026.

Question 5

What is PatentVest's current news sentiment?

Accepted Answer

Aggregate sentiment score: 40 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is PatentVest in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving PatentVest?

Accepted Answer

PatentVest Report on Obesity Drug IP (May 08, 2026, 6 articles).

Question 8

How did the "PatentVest Report on Obesity Drug IP" event impact PatentVest?

Accepted Answer

PatentVest released a comprehensive report on the triple-agonist obesity drug market, positioning itself as a key provider of IP intelligence and strategy in the biotechnology sector.

Question 9

How did the "PatentVest to Present at Planet MicroCap" event impact PatentVest?

Accepted Answer

PatentVest announced its presentation at Planet MicroCap Las Vegas, where it will discuss intellectual property strategy and AI-native IP services, aiming to attract investors and clients.

Question 10

How did the "PatentVest analyzes OpenAI patent portfolio" event impact PatentVest?

Accepted Answer

PatentVest published the report, showcasing its IP intelligence capabilities. The analysis may enhance its reputation and attract clients.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.